Abbott Labs' Diversification And Diagnostics Leverage Paying Off Now [Seeking Alpha]
Boston Scientific Corporation (BSX)
Last boston scientific corporation earnings: 4/29 06:30 am
Check Earnings Report
US:NYSE Investor Relations:
investors.bostonscientific.com
Company Research
Source: Seeking Alpha
SummaryAbbott posted better than expected revenue and margins in the first quarter, despite a sharp drop-off in most device businesses in the month of March.Abbott is focusing on ramping up production capacity for its three approved Covid-19 tests, and testing is a major gating factor to reopening the U.S. economy.The appeal of Abbott as a Covid-19 play is understandable, with both consumer-driven recurrent revenue and leverage in diagnostics, but the valuation looks fair now.As everyone scrambles to figure out what Covid-19 will mean for health care providers, patients, and companies,Abbott LabsABTAs a huge and well-followed company, it doesn’t surprise me that this is now reflected in the share price. Relative to a stock likeStrykerSYKA Good Quarter, With A Sharp Change In MarchAbbott saw a major shift in the business in March, as health care facilities largely shut their doors to non-essential/non-emergent customers. Even so, the March quarter was strong relative to expectations, w
Show less
Read more
Impact Snapshot
Event Time:
BSX
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
BSX alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
BSX alerts
High impacting Boston Scientific Corporation news events
Weekly update
A roundup of the hottest topics
BSX
News
- What Could Shift the Story for Boston Scientific After Strong Results and Analyst Optimism [Yahoo! Finance]Yahoo! Finance
- Boston Scientific (NYSE:BSX) had its "buy" rating reaffirmed by analysts at BTIG Research. They now have a $132.00 price target on the stock.MarketBeat
- Boston Scientific Corporation's (NYSE:BSX) Stock Has Been Sliding But Fundamentals Look Strong: Is The Market Wrong? [Yahoo! Finance]Yahoo! Finance
- The 7 Things That Make You Interesting In 2026 [Forbes]Forbes
- Cala Health Expands Leadership Team to Support Growing Adoption of the Cala TAPS Therapy for Tremor [Yahoo! Finance]Yahoo! Finance
BSX
Earnings
- 10/22/25 - Beat
BSX
Sec Filings
- 12/2/25 - Form 4
- 12/1/25 - Form 4
- 12/1/25 - Form 144
- BSX's page on the SEC website